Last reviewed · How we verify
Placebo (for Voltaren)
Placebo (for Voltaren) is a Small molecule drug developed by Ache Laboratorios Farmaceuticos S.A.. It is currently in Phase 3 development for Control arm in Phase 3 clinical trial for Voltaren (diclofenac) indication. Also known as: Placebo (for Voltaren 50mg).
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control arm in Phase 3 clinical trial for Voltaren (diclofenac) indication.
At a glance
| Generic name | Placebo (for Voltaren) |
|---|---|
| Also known as | Placebo (for Voltaren 50mg) |
| Sponsor | Ache Laboratorios Farmaceuticos S.A. |
| Modality | Small molecule |
| Therapeutic area | Pain/Inflammation (as control for Voltaren) |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials. Any observed effects result from patient expectation, the therapeutic context, and natural disease progression rather than direct molecular action. In this case, it serves as a comparator control for Voltaren (diclofenac) in a Phase 3 trial.
Approved indications
- Control arm in Phase 3 clinical trial for Voltaren (diclofenac) indication
Common side effects
Key clinical trials
- KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism (NA)
- Comparison of the Effectiveness of Therapeutic Ultrasound and Phonophoresis in Chronic Low Back Pain (NA)
- Topical Chemoprevention of Skin Cancer Biomarkers (PHASE2)
- A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms (PHASE3)
- Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer (PHASE2)
- The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain (NA)
- A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee (PHASE3)
- Topical Diclofenac for Prevention of Radiation-induced Dermatitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Voltaren) CI brief — competitive landscape report
- Placebo (for Voltaren) updates RSS · CI watch RSS
- Ache Laboratorios Farmaceuticos S.A. portfolio CI
Frequently asked questions about Placebo (for Voltaren)
What is Placebo (for Voltaren)?
How does Placebo (for Voltaren) work?
What is Placebo (for Voltaren) used for?
Who makes Placebo (for Voltaren)?
Is Placebo (for Voltaren) also known as anything else?
What development phase is Placebo (for Voltaren) in?
Related
- Manufacturer: Ache Laboratorios Farmaceuticos S.A. — full pipeline
- Therapeutic area: All drugs in Pain/Inflammation (as control for Voltaren)
- Indication: Drugs for Control arm in Phase 3 clinical trial for Voltaren (diclofenac) indication
- Also known as: Placebo (for Voltaren 50mg)
- Compare: Placebo (for Voltaren) vs similar drugs
- Pricing: Placebo (for Voltaren) cost, discount & access